Group One Trading, L.P. Synlogic, Inc. Transaction History

Group One Trading, L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.89 - $2.47 $5,050 - $14,017	-5,675 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$1.63 - $2.55 $326 - $509	-200 Reduced 3.4%	5,675 $14,000
Q4 2021 Feb 11, 2022	SELL	$2.27 - $3.0 $7,720 - $10,203	-3,401 Reduced 36.66%	5,875 $14,000
Q3 2021 Nov 12, 2021	SELL	$2.45 - $4.1 $3,920 - $6,559	-1,600 Reduced 14.71%	9,276 $28,000
Q2 2021 Aug 10, 2021	BUY	$3.0 - $4.39 $12,735 - $18,635	4,245 Added 64.02%	10,876 $42,000
Q1 2021 May 12, 2021	BUY	$2.2 - $5.05 $7,455 - $17,114	3,389 Added 104.53%	6,631 $24,000
Q4 2020 Feb 10, 2021	BUY	$1.85 - $2.54 $5,997 - $8,234	3,242 New	3,242 $7,000
Q3 2020 Nov 12, 2020	SELL	$1.85 - $2.57 $3,137 - $4,358	-1,696 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$1.59 - $2.51 $1,437 - $2,269	-904 Reduced 34.77%	1,696 $3,000
Q1 2020 May 13, 2020	BUY	$1.39 - $3.19 $3,474 - $7,975	2,500 Added 2500.0%	2,600 $4,000
Q3 2019 Nov 12, 2019	BUY	$2.12 - $9.37 $212 - $936	100 New	100 $0

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.